Definition of yttrium Y 90 DOTA monoclonal antibody HuAFP31

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate NCI Responds to Hurricanes The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

Search for

Starts with

Contains

yttrium Y 90 DOTA monoclonal antibody HuAFP31 (IH-tree-um … MAH-noh-KLOH-nul AN-tih-BAH-dee …)

A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can locate and bind to tumor cells that make a protein called alpha fetoprotein (AFP). It is linked to a radioactive substance called yttrium Y 90, which may help kill the cancer cells. Yttrium Y 90 DOTA monoclonal antibody HuAFP31 is a type of radioimmunoconjugate.

Previous Definitions:	YM598, yoga, yohimbe, yttrium, yttrium Y 90
Next Definitions:	yttrium Y 90 DOTA-biotin, yttrium Y 90 DOTA-tyr3-octreotide, yttrium Y 90 edotreotide, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 SMT 487